Scientific Poster Abstracts
19-21 October 2026
RAI Convention Centre, Amsterdam
Information for presenters
Please print your poster in advance in portrait orientation, A0 size (118.9 cm high × 84.1 cm wide) . Bring your poster on day 1 of the event (Tuesday 20 October) . Pins will be available to mount your poster.
You can choose an available space to display your poster on a first-come, first-served basis . Please be mindful of other poster presenters and leave enough room for neighbouring posters.
There are 2 dedicated poster presentation sessions , however, you are welcome to stay by your poster whenever you please:
- Tuesday 20 October : 13:30 - 14:00
- Wednesday 21 October : 13:30 - 14:00
The Poster Zone
2026 poster submissions
Browse the authors, organisations and research titles below.
95 submitted posters
| Author | Organisation or academic institution | Poster title |
|---|---|---|
| Abigail Harris | SeromYx Systems | Beyond Antibody Titers: High-Throughput Fc Functional Profiling to Identify Immune Correlates of Vaccine Outcomes |
| Alexander Kadijevic | Sani Membranes A/S | Vibro® Membrane Filtration by Sani Membranes |
| Alice Lilley | Francis Crick Institute | Investigation of Potential Cross-Protection Conferred by the Seasonal Influenza Vaccine against Swine Influenza A Viruses of Pandemic Potential. |
| Andrew Goodhead | Carterra | Strategies for Scalable and Sensitive Determination of High Affinity and Slow Dissociating Binding Interaction Kinetics in Antibody Discovery |
| Andrew Van Kessel | VIDO, University of Saskatchewan | MSX-1 – a novel bovine TB vaccine candidate that is protective but does not interfere with the PPD test |
| Anke Stuurman | P95 Julius Clinical | id.DRIVE: An open public-private partnership for infectious diseases studies on vaccines, burden of disease and therapeutics in Europe and beyond |
| Annick de Vries | Immuneed AB | Preclinical testing of oligonucleotides using a human whole-blood in vitro new approach methodology (NAM) |
| Benjamin Mulot | Institut Gustave Roussy - UMR9018 | Vaccine platform based on capsid-like particles derived from bacteriophage T5: from development to recombinant production |
| Benoit Maisonneuve | NETRI | New Approach Methodologies in a Changing Regulatory Landscape: From Animal Replacement to Decision-Relevant Evidence in Vaccine Development |
| Birgit Rogell | Roche CustomBiotech | Benchmarking the Endonuclease EndoCleave in Measles Virus Vaccine Manufacturing: Navigating Complex Host Cell DNA Clearance |
| Bjørge Westereng | Norwegian University of Life Sciences Faculty of Chemistry Biotechnology and Food Science | A widely applicable method for the isolation of unaltered cell wall glycopolymers from Gram-positive bacteria |
| Caroline de Melo | Amsterdam UMC | Intratracheal CD169-targeted liposomal vaccine in experimental lung cancer immunotherapy |
| Christina Go | Integral Molecular | Advancing Filovirus Preparedness with Scalable Neutralization Assays and Deep Antibody Characterization |
| Corinna Schüß | Institute of Drug Discovery, Leipzig University | Advancing coronavirus vaccine design for pandemic preparedness using AI-based methods |
| David E Anderson | Phoenix Therapeutics | A novel immunotherapeutic induces rapid, broadly protective trained immunity against gram-negative bacteria |
| Deeksha Parashar | Triangulate Health | Quantifying the cost of inaction on under-immunisation in Georgia, the Republic of Moldova and Ukraine: a five-component cost-of-inaction and return-on-investment analysis |
| Derek Fleming | CIDRAP, University of Minnesota | Global funding trends in coronavirus vaccine research and development and implications for future pandemic preparedness |
| Diana Fontinha | Gulbenkian Institute for Molecular Medicine (GIMM) | Targeting Plasmodium vivax malaria through monoclonal antibody development |
| Diana Moita | Gulbenkian Institute for Molecular Medicine | Unveiling the impact of gut microbiota on vaccination against malaria |
| Dr. Blerina Shkodra | leon-nanodrugs GmbH | Scaling personalized medicine: A cost-efficient approach for tomorrow's mRNA therapies |
| Edward Grahame | Cytiva | Neoantigen-based personalized cancer vaccine: LNP- mediated delivery of multi-epitope mRNA extends survival in aggressive melanoma cancer model |
| Efstathios Giotis | University of Essex | Engineering an optimised Fowlpox virus vector with self-adjuvantating properties |
| Elise Rosati | ImmuneSpec | Immunopeptidomics-based validation of antigen presentation as a tool for vaccine optimization |
| Elissandro Klein | Biotech One | Continuous Production of Lipid-Based Nanoparticles Using Supercritical CO₂ |
| Elsa Abranches | ViSync Technologies | Stabilisation of Viral Vectors Beyond the Cold Chain |
| Eva Illuzzi | Boston Children's Hospital, Precision Vaccines Program | Alum-Adjuvanted Vaccines and Adjuvants Induce Distinct Age-Specific Trained Immunity Effects In vitro |
| Eyob Addise Workneh | Gulbenkian Institute for Molecular Medicine | Assessing Transmission-Blocking Immunity Elicited by Whole-Sporozoite Vaccines for Plasmodium vivax |
| Fan Yan | Acuitas Therapeutics | Lipid Nanoparticles Enabling Potent Immune Response to mRNA Cancer Vaccines |
| Febby Valentine Purwadi | University of Santiago de Compostela | Development of protein antigen-loaded nanocarriers for intranasal pneumococcal vaccine |
| Fiona Taylor | Getinge Applikon | 1. Vero cell growth and EV71_C4 replication capacity in small-scale customizable single-use bioreactors |
| Fran Van Heuverswyn | Immunity for Health vzw | From Health Cluster to Global Impact: Connecting Vaccine Expertise for Health Security |
| Ghania Chikh | Acuitas Therapeutics | Advanced LNP Technology for Infectious Disease Vaccines |
| GISUB CHOI | CLIPS BnC | Evaluation of a Multivalent Vaccine Targeting Staphylococcus aureus Pore-Forming Toxins in Mouse SSTI and Therapeutic-Prophylactic Challenge Models |
| Gorben Pijlman | Wageningen University, Netherlands | Insect-cell based nanoparticle vaccine platform to combat zoonotic arthropod-borne viruses |
| Hollie Havens | CRIO | Characterizing the Protocol-Guided Source Preparation Process at Investigative Sites |
| Huanhuan Li | Queen's University Belfast | Self-Indicating Dissolving Microneedles: Closing the Dose Confirmation Gap in Vaccine Delivery |
| Ilse Broeders | Lifelines | Lifelines a Real world datasource for vaccine effectiveness studies |
| Jana Canipel | ImmuneSpec | Ultra-sensitive immunopeptidomics for non-canonical antigen detection |
| Jelle klein | SGS CPU | Belgium: a highly favourable landscape for human challenge studies |
| Jelle klein | SGs CPU | Clinical validation of the rsv-nica human challenge model |
| Jeonghun Kim | Progeneer | ProLNG: A Versatile TLR7/8 Agonist Adjuvant Platform for Th1-Mediated Cellular Immune Response |
| Jessica Taaffe | Center for Infectious Disease Research and Policy | Investing Beyond the Pandemic: Progress and Persistent Gaps in Coronavirus Vaccine Policy and Financing |
| Jorg Bolder | Getinge Applikon | Raining blood scale-up of ex vivo erythroblast expansion for the production of RBCs for transfusion purposes |
| Josephine Blersch | immunXnano | DZNE | Functional Immune Profiling in Primary Human Cells to Accelerate Nanomedicine and Vaccine Adjuvant Development |
| Joshua Wiggins | University of Nebraska | A Multi-Strain H5N1 Consensus Based Viral-Vectored Livestock Vaccine |
| Julia Baena Paz | Universidade de Santiago de Compostela (USC) | Next-generation nasal vaccines: engineering mRNA-Nanoassemblies for in vivo mucosal delivery |
| Juliana Cassataro | University of San Martin | Protein subunit adapted ARVAC COVID-19 Vaccination Induces Cross-Variant and Long-Term T-Cell Memory in a Phase 4 Study |
| Julien Flaig | Spegegant | Social and fiscal impacts of seasonal flu vaccination in France: spillover effects and structural factors |
| Kelly da Costa | Univeristy of Sheffield | Title: Mapping Protective Epitopes for Next-Generation Vaccine Design: High-Throughput PhIP-Seq Profiling in a Longitudinal Gambian Cohort |
| Kevin O'Neill | Uvax Bio, LLC | Nanoparticle Display of Prefusion-Stabilized MERS-CoV Spike Induces Robust Neutralization and Confers Complete Single-Dose Protection in hDPP4 Transgenic Mice |
| Koert Stittelaar | VirusBank Platform - KU Leuven | The VirusBank Platform: A unique research infrastructure promoting enhanced preparedness against future epi- and pandemics |
| KOSHALKO Oksana | WHO Country Office in Ukraine | Poliovirus surveillance and immunization trends in Ukraine during Wartime: strong system performance amid persistent vulnerabilities |
| Laurens Vergauwen | Merck Chemicals N.V. | Feed it Right, Make More: Real-Time Raman Monitoring of Nucleotide Depletion and Refeeding Strategies to Boost mRNA Yield |
| Lexi Hammer | Integral Molecular | Rapid Neutralization Assays: Influenza Virus-Like Particles for Flexible Readouts |
| Linda Dexlin Mellby | Cellevate AB | Novel nanofiber microcarriers enable high-yield, scalable viral vaccine production in stirred-tank bioreactor systems |
| Luz Elena Moreno | The Emmes Group | Accelerating Global Vaccine Timelines: Leveraging AI-Driven Protocol Digitization and Localized Operational Networks to Beat Enrollment Targets and Minimize Deviations |
| Madhavsai Kirit Gajjar | Thermo Fisher Scientific | Animal-origin–free influenza manufacturing: Recombinant trypsin enables streamlined MDCK scale-up and effective virus activation |
| Magdalena Shumanska | German Center for Neurodegenerative Diseases (DZNE) | High-throughput assay for spatiotemporal profiling of T-cell and monocyte cross-talk |
| Maja Leskovec | Sartorius BIA Separations d.o.o. | Streamlined Chromatographic Purification and Concentration of Bacteriophage COP-135 from Klebsiella pneumoniae Lysate |
| Manuel Garcia Ricardo | Max Planck Institute of Colloids and Interfaces | Fully Synthetic Liposomal Platform for Next-Generation Carbohydrate Vaccines |
| Marcus Curl | InVitria | Recombinant Animal-Free Human Serum Albumin Stabilizes Enveloped Viral Particles Across Downstream Processing and Final Formulation |
| Margarita Pertseva | Alithea Biotechnology GmbH | FindingNeo: neoantigen prioritisation using immunopeptidomic evidence from the world's largest HLA ligand dataset |
| Margaux Mesle | Mesle Insights | Examining seasonal influenza vaccination coverage in the Gulf Cooperation Council countries: strengthening prevention and control |
| Maria Laura Dona Mourão | Boston Children's Hospital | Trends in Maternal RSV Vaccination and Neonatal RSV Prophylaxis in the NICU Across Two Consecutive RSV Seasons |
| Maria P Almario | VECOL S.A. | Decentralizing Biopharmaceutical Scaling: A Techno-Economic Evaluation of Hybrid Modular Facilities to Overcome International CMO Bottlenecks and Enhance Regional Vaccine Manufacturing |
| Marissa Gripenberg | FVR - Finnish Vaccine Research | FVR - Finnish Vaccine Research: Upscaling Vaccine Trial Recruitment Through Digital Transformation |
| Masahiro Taniguchi | KAICO Ltd. | Translational Development of a Silkworm–Baculovirus Norovirus Vaccine Platform: From Research to First-in-Human Readiness and Future Oral/Mucosal Vaccination |
| Mats Lundgren | Abera Bioscience | Mucosal influenza vaccination using an outer membrane vesicle platform |
| Mingmin Liao | VIDO, University of Saskatchewan | A Bivalent RSV/PIV3 Vaccine Induces Durable Protective Immunity Against RSV and PIV3 |
| Moises Maestro-Lopez | PUXANO | Synergizing antigen design AI models and cryoEM innovations |
| MYKHAILO MURZA | WHO Country Office in Ukraine | Scaling up digital tools to support data-driven decision-making on vaccine supplies during the ongoing war in Ukraine |
| Nayeli Esparza | Laval University | Integration of the Feldan Shuttle Peptide into Lipid Nanoparticles (LNPs) to Enhance Endosomal Escape and Cytosolic Delivery of mRNA. |
| Nicola Shaw | Unchained Labs | High-throughput Screening of Formulations & Process Conditions for LNP Synthesis |
| Nicolas Noulin, PhD | NoulinBioConsulting | From Respiratory Human Challenge to Field Efficacy: A Structured Analysis of Four Vaccine Programmes |
| Rebecca Dabbs | Patronus Biotech | Toxicological evaluation of a synthetic QS-21 adjuvant in a tuberculosis vaccine candidate —Demonstrating safety and immunological equivalence to natural reference |
| Rio Yamagishi | Terumo corporation | Performance and Application of the Immucise Intradermal Injection System: Exploring the Potential of Intradermal Vaccination Across Conventional and mRNA-LNP Vaccine Platforms |
| Rowan Wolters | Radboudumc | Protection from viruses with epidemic and pandemic disease outbreak potential through development and clinical testing of a novel capsid virus like particle vaccine (VICI-DISEASE) |
| Santtu Heinonen | FVR - Finnish Vaccine Research | Infant respiratory syncytial virus infection and childhood asthma: a nationwide registry-based, sibling-controlled, and genome-wide association study |
| Seonyoung Park | Animal and Plant Quarantine Agency (APQA) | Phenotypic and genomic characterization of Actinobacillus pleuropneumoniae serovars 2 and 5 in inactivated animal vaccine in South Korea |
| Sergi Rodà | Nostrum Biodiscovery | Advancing Vaccine Design with AI and Physics-Based Modelling Platforms |
| Shaquib Rahman Ansari | UMC Utrecht | Mapping the Structure-Function Relationships of Self-Amplifying RNA-loaded Lipid Nanoparticles: A Quality by design approach |
| Sileshi Solomon Mekonnen | Ethiopian Ministry of Health | Reaching Every Child: From Identifying Missed Children to Closing the Immunization Gap in Ethiopia |
| Suvi Haimi | Velocin | Engineered enterovirus protein-based vaccines and a parametric design system for repeatable vaccine development |
| Thomas Robert | Univercells Technologies, by Donaldson | Next-generation vaccine manufacturing: producing millions of doses in a compact footprint with drastic cost reduction |
| Tilia Zinnecker | Sartorius Stedim Biotech GmbH | Intensification Strategies for Influenza A Virus Production in Suspension MDCK Cells |
| Tom Bosschaerts | ImmuneWatch | Immune monitoring of vaccines and immunotherapies: novel insights using T-cell receptor sequencing data analysis |
| Waleed Faisal | ArrayPatch ltd | Polymer-Free Dissolving Microneedles for Next-Generation Transdermal Delivery of Peptide Therapeutics |
| Winnie Kerstens | KU Leuven | ArboSero: a High-Throughput and Validated Arbovirus Serology Platform |
| Xiaoli Li | Cellplus Biotechnology | Bridging Transfection and Stable Fed-Batch Production in HEK293 Cells |
| Yacine El Aroussi | Thermo Fisher Scientific | Informed Peptone Substitution Enables Quick AO-to-AOF Media Conversions for Fastidious Bacterial Species |
| Yann Le Duff | Medicines and Healthcare products Regulatory Agency | CIDR: increasing pandemic and epidemic preparedness through the provision of quality reagents underpinning the development of vaccines against emerging viruses. |
| Yanping Gong | Queen's University and Kingston Health Sciences Centre, Canada | Multiplex IGRA Reveals Attenuated Cellular Immune Responses to SARS-CoV-2 in Transplant Recipients After Booster Vaccination |
| Yoonseon Park | Gil medical center, Gachon university college of medicine | To do or not Universal MMR vaccination in view of cost benefit analysis |
| Ysaline ROLAND | Naobios | IMPLEMENTATION OF A 10L PERFUSION PROCESS TO PRODUCE ACTIVE HIV-1 AT A MULTIPLE 50L SCALE FOR AIDS VACCINE CLINICAL PHASE II PURPOSE |
| Zeger de Vente | Hamilton AG | Real-time Monitoring of DCO2 in Addition to DO In-situ PAT applied to Hybridoma Cell Culture |
No matching posters found.
Try a different name, organisation or keyword, or reset the filters.
This directory lists submitted posters. Inclusion does not confirm acceptance or selection for an Expo Stage presentation.
Stay up-to-date
Join our mailing list to receive exclusive content and offers.
Created by
Terrapinn is proud to be a member of isla.
Working together to build sustainable events